These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4736246)

  • 21. Potency switch between CHK1 and MK2: discovery of imidazo[1,2-a]pyrazine- and imidazo[1,2-c]pyrimidine-based kinase inhibitors.
    Meng Z; Ciavarri JP; McRiner A; Zhao Y; Zhao L; Reddy PA; Zhang X; Fischmann TO; Whitehurst C; Arshad Siddiqui M
    Bioorg Med Chem Lett; 2013 May; 23(10):2863-7. PubMed ID: 23587425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a novel oxidation product from yellow fluorophore in the complex of apoPholasin and dehydrocoelenterazine.
    Inouye S; Nakamura M; Taguchi J; Hosoya T
    Bioorg Med Chem Lett; 2020 Oct; 30(19):127435. PubMed ID: 32717370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and evaluation of imidazo[1,5-a]pyrazines as corticotropin releasing hormone receptor ligands.
    Hartz RA; Gilligan PJ; Nanda KK; Tebben AJ; Fitzgerald LW; Miller K
    Bioorg Med Chem Lett; 2002 Feb; 12(3):291-4. PubMed ID: 11814780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imidazo-pyrazine derivatives as potent CXCR3 antagonists.
    Du X; Gustin DJ; Chen X; Duquette J; McGee LR; Wang Z; Ebsworth K; Henne K; Lemon B; Ma J; Miao S; Sabalan E; Sullivan TJ; Tonn G; Collins TL; Medina JC
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5200-4. PubMed ID: 19631529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and c-Src inhibitory activity of imidazo[1,5-a]pyrazine derivatives as an agent for treatment of acute ischemic stroke.
    Mukaiyama H; Nishimura T; Kobayashi S; Ozawa T; Kamada N; Komatsu Y; Kikuchi S; Oonota H; Kusama H
    Bioorg Med Chem; 2007 Jan; 15(2):868-85. PubMed ID: 17095233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biological evaluation of benzo[4,5]imidazo[1,2-c]pyrimidine and benzo[4,5]imidazo[1,2-a]pyrazine derivatives as anaplastic lymphoma kinase inhibitors.
    Tardy S; Orsato A; Mologni L; Bisson WH; Donadoni C; Gambacorti-Passerini C; Scapozza L; Gueyrard D; Goekjian PG
    Bioorg Med Chem; 2014 Feb; 22(4):1303-12. PubMed ID: 24468632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Azapurine nucleosides. 3. Synthesis of 7-( -D-ribofuranosyl)imidazo(4,5-d)-v-triazin-4-one(2-azainosine) and related derivatives.
    Kawana M; Ivanovics GA; Rousseau RJ; Robins RK
    J Med Chem; 1972 Aug; 15(8):841-3. PubMed ID: 4339771
    [No Abstract]   [Full Text] [Related]  

  • 28. Structure based design of novel 6,5 heterobicyclic mitogen-activated protein kinase kinase (MEK) inhibitors leading to the discovery of imidazo[1,5-a] pyrazine G-479.
    Robarge KD; Lee W; Eigenbrot C; Ultsch M; Wiesmann C; Heald R; Price S; Hewitt J; Jackson P; Savy P; Burton B; Choo EF; Pang J; Boggs J; Yang A; Yang X; Baumgardner M
    Bioorg Med Chem Lett; 2014 Oct; 24(19):4714-4723. PubMed ID: 25193232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery and optimization of a series of imidazo[4,5-b]pyrazine derivatives as highly potent and exquisitely selective inhibitors of the mesenchymal-epithelial transition factor (c-Met) protein kinase.
    Zhao F; Zhang J; Zhang L; Hao Y; Shi C; Xia G; Yu J; Liu Y
    Bioorg Med Chem; 2016 Sep; 24(18):4281-4290. PubMed ID: 27448775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of substituted imidazo[1,5-a]pyrazines via mono-, di-, and directed remote metalation strategies.
    Board J; Wang JX; Crew AP; Jin M; Foreman K; Mulvihill MJ; Snieckus V
    Org Lett; 2009 Nov; 11(22):5118-21. PubMed ID: 19842687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 1,3-Disubstituted-imidazo[1,5-a]pyrazines as insulin-like growth-factor-I receptor (IGF-IR) inhibitors.
    Mulvihill MJ; Ji QS; Werner D; Beck P; Cesario C; Cooke A; Cox M; Crew A; Dong H; Feng L; Foreman KW; Mak G; Nigro A; O'Connor M; Saroglou L; Stolz KM; Sujka I; Volk B; Weng Q; Wilkes R
    Bioorg Med Chem Lett; 2007 Feb; 17(4):1091-7. PubMed ID: 17127062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological evaluation of novel 2-deoxy-4-thio-imidazole nucleosides.
    Wang Y; Inguaggiato G; Jasamai M; Shah M; Hughes D; Slater M; Simons C
    Bioorg Med Chem; 1999 Mar; 7(3):481-7. PubMed ID: 10220034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of a highly potent orally bioavailable imidazo-[1, 2-a]pyrazine Aurora inhibitor.
    Yu T; Zhang Y; Kerekes AD; Tagat JR; Doll RJ; Xiao Y; Esposite S; Hruza A; Belanger DB; Voss M; Rainka MP; Basso A; Liu M; Liang L; Sui N; Prelusky D; Rindgen D; Zhang L
    Bioorg Med Chem Lett; 2018 May; 28(8):1397-1403. PubMed ID: 29545102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Molecular chameleons". Design and synthesis of C-4-substituted imidazole fleximers.
    Seley KL; Salim S; Zhang L
    Org Lett; 2005 Jan; 7(1):63-6. PubMed ID: 15624978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Solid-phase synthesis of 2,5-dihydro-1H-pyrroles, 1,3-dioxo-2,3,5,7a-tetrahydro-1H-pyrrolo[1,2-c]imidazoles and 1,4-dioxo-1,2,3,4,6,8a-hexahydropyrrolo[1,2-a]pyrazines using a supported selenium resin.
    Huang X; Xu JF
    J Comb Chem; 2009; 11(3):350-4. PubMed ID: 19220032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and cytokinin activity of fluorescent 7-Phenylethynylimidazo[4,5-b]pyridine and its riboside.
    Nishikawa S; Kurono M; Shibayama K; Okuno S; Inagaki M; Kashimura N
    J Agric Food Chem; 2000 Jun; 48(6):2559-64. PubMed ID: 10888584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New imidazo(1,2-a)pyrazine derivatives with bronchodilatory and cyclic nucleotide phosphodiesterase inhibitory activities.
    Vitse O; Laurent F; Pocock TM; Bénézech V; Zanik L; Elliott KR; Subra G; Portet K; Bompart J; Chapat JP; Small RC; Michel A; Bonnet PA
    Bioorg Med Chem; 1999 Jun; 7(6):1059-65. PubMed ID: 10428374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bisdeoxycoelenterazine derivatives for improvement of bioluminescence resonance energy transfer assays.
    Levi J; De A; Cheng Z; Gambhir SS
    J Am Chem Soc; 2007 Oct; 129(39):11900-1. PubMed ID: 17850082
    [No Abstract]   [Full Text] [Related]  

  • 39. Novel 2-phenylquinolin-7-yl-derived imidazo[1,5-a]pyrazines as potent insulin-like growth factor-I receptor (IGF-IR) inhibitors.
    Mulvihill MJ; Ji QS; Coate HR; Cooke A; Dong H; Feng L; Foreman K; Rosenfeld-Franklin M; Honda A; Mak G; Mulvihill KM; Nigro AI; O'Connor M; Pirrit C; Steinig AG; Siu K; Stolz KM; Sun Y; Tavares PA; Yao Y; Gibson NW
    Bioorg Med Chem; 2008 Feb; 16(3):1359-75. PubMed ID: 17983756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, antileishmanial activity and cytotoxicity of 2,3-diaryl- and 2,3,8-trisubstituted imidazo[1,2-a]pyrazines.
    Marchand P; Bazin MA; Pagniez F; Rivière G; Bodero L; Marhadour S; Nourrisson MR; Picot C; Ruchaud S; Bach S; Baratte B; Sauvain M; Pareja DC; Vaisberg AJ; Le Pape P
    Eur J Med Chem; 2015 Oct; 103():381-95. PubMed ID: 26383125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.